Advertisement

U.S. markets closed

S&P Futures
6,011.75
+24.75(+0.41%)
Dow Futures
44,622.00
+227.00(+0.51%)
Nasdaq Futures
20,948.50
+98.75(+0.47%)
Russell 2000 Futures
2,437.00
+23.40(+0.97%)
Crude Oil
71.24
0.00(0.00%)
Gold
2,714.70
+2.50(+0.09%)

Equillium, Inc. (EQ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

0.7110

-0.0090

(-1.25%)

At close: 04:00PM EST

0.7399

+0.03

(+4.06%)

After hours:

06:01PM EST

Trade prices are not sourced from all markets

All

Business Wire
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
LA JOLLA, Calif., November 13, 2024--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the third quarter 2024 and provided corporate and clinical updates.
Business Wire
Equillium to Present at the Stifel Healthcare Conference
LA JOLLA, Calif., November 13, 2024--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Stifel Healthcare Conference taking place in New York on November 18 & 19, 2024.